JP TSE 4565 Pharmaceutical

Nxera Pharma Co., Ltd.

ネクセラファーマ株式会社

Revenue

¥29.6B

≈ $187.5M

Net income

−¥12.5B

≈ −$79.3M

Income taxes paid

¥241M

≈ $1.5M

Total assets

¥135B

≈ $853.3M

Equity ratio

45.3%

Ranked #2,654 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Dec 2025	¥29.6B	−¥12.5B	−¥2.4B	¥241M	¥135B	¥61.0B	45.3%	EDINET (consol.)
Dec 2024	¥28.8B	−¥4.8B	¥176M	¥428M	¥151B	¥68.5B	45.2%	EDINET (consol.)
Dec 2023	¥12.8B	−¥7.2B	—	—	¥157B	¥66.8B	42.5%	EDINET (consol.)
Dec 2022	¥15.6B	¥382M	—	—	¥99.4B	¥57.9B	58.3%	EDINET (consol.)
Dec 2021	¥17.7B	¥1.0B	—	—	¥97.0B	¥57.5B	59.3%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.